Treatment of chronic atrial fibrillation with warfarin or aspirin: A cost-effectiveness and cost-utility analysis.

被引：0
|
作者：
Zarnke, KB [1 ]
Levine, MAH [1 ]
OBrien, B [1 ]
机构：
[1] ST JOSEPHS HOSP, CTR EVALUAT MED, HAMILTON, ON, CANADA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1996年 / 59卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：PII89 / PII89
页数：1
相关论文
共 50 条
  • [11] Cost-effectiveness of Apixaban versus Warfarin and Aspirin in Sweden for Stroke Prevention in Patients with Atrial Fibrillation
    Lanitis, Tereza
    Kongnakorn, Thitima
    Jacobson, Lena
    De Geer, Anna
    THROMBOSIS RESEARCH, 2014, 134 (02) : 278 - 287
  • [12] THE COST-EFFECTIVENESS AND COST-UTILITY OF PALIPERIDONE PALMITATE IN THE TREATMENT OF SCHIZOPHRENIA IN GUATEMALA
    Obando, C. A.
    Gonzalez, L.
    Muschett, D.
    VALUE IN HEALTH, 2013, 16 (07) : A695 - A695
  • [13] COST-EFFECTIVENESS ANALYSIS OF APIXABAN IN THE TREATMENT OF ATRIAL FIBRILLATION IN MEXICO
    Galindo-Suarez, R. M.
    Davila-Veites, A.
    Olguin-Sanchez, J. F.
    Haddad, A.
    del Angel-Martinez, J.
    Mucino-Ortega, E.
    VALUE IN HEALTH, 2013, 16 (07) : A524 - A524
  • [14] PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION: COST-UTILITY ANALYSIS OF RIVAROXABAN VERSUS WARFARIN IN SLOVAKIA
    Psenkova, M.
    Lukac, M.
    Mackovicova, S.
    Stachova, M.
    Bielik, J.
    Pietsch, G. A.
    Asukai, Y.
    Lloyd, A.
    Evers, T.
    VALUE IN HEALTH, 2012, 15 (07) : A375 - A375
  • [15] Analysis of cost-effectiveness and cost-utility for immunosuppressive protocols in renal transplantation
    Keown, P
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 1140 - 1141
  • [16] Posttransplant Hepatocellular Carcinoma Surveillance A Cost-effectiveness and Cost-utility Analysis
    Hessheimer, Amelia J.
    Vargas-Martinez, Ana Magdalena
    Trapero-Bertran, Marta
    Navasa, Miquel
    Fondevila, Constantino
    ANNALS OF SURGERY, 2023, 277 (02) : E359 - E365
  • [17] A cost-effectiveness and cost-utility study of lung transplantation
    Vasiliadis, HM
    Collet, JP
    Penrod, JR
    Ferraro, P
    Poirier, C
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (09): : 1275 - 1283
  • [18] Cost-effectiveness and Cost-utility for Treating Trauma in Psychosis
    van der Gaag, Mark
    de Bont, Paul
    van der Vleugel, Berber
    de Roos, Carlijn
    de Jongh, Ad
    van Minnen, Agnes
    van den Berg, David
    EARLY INTERVENTION IN PSYCHIATRY, 2018, 12 : 21 - 21
  • [19] Cost-Effectiveness and Cost-Utility Analyses of Antireflux Medicine
    Gockel, Ines
    Lange, Undine Gabriele
    Schuermann, Olaf
    Jansen-Winkeln, Boris
    Sibbel, Rainer
    Lyros, Orestis
    von dercks, Nikolaus
    GESUNDHEITSWESEN, 2019, 81 (12) : 1048 - 1056
  • [20] Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin
    Lee, Soyon
    Anglade, Moise W.
    Meng, Joy
    Hagstrom, Kelly
    Kluger, Jeffrey
    Coleman, Craig I.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2012, 5 (04): : 472 - 479
12345